Rhythmic pattern in pain and their chronotherapy

Advanced Drug Delivery Reviews

Volumn 59, Issue 9-10, 2007, Pages 883-895

  Bruguerolle, Bernard ^a   Labrecque, Gaston ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

Aspirin; Chronokinetics; Chronopharmacology; Chronotherapy; Computer controlled analgesia; Drug delivery modeling; Local anesthetics; Morphine; NSAIDs; Opioids; Pain; Paracetamol; Placebo; Tramadol; Transdermal systems

Indexed keywords

ASPIRIN; CHRONOKINETICS; CHRONOPHARMACOLOGY; DRUG-DELIVERY MODELING;

DISEASE CONTROL; HEALTH CARE;

DRUG DELIVERY;

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BUPIVACAINE; BUPRENORPHINE; BUTYLATED HYDROXYANISOLE; CELECOXIB; CHRONOVERA; EMLA; ETIDOCAINE; FENTANYL; FLURBIPROFEN; GLYCERYL TRINITRATE; HYDROMORPHONE; IBUPROFEN; INDOMETACIN; KETOPROFEN; LIDOCAINE; LOCAL ANESTHETIC AGENT; MEPIVACAINE; MORPHINE; MORPHINOMIMETIC AGENT; N(G) NITROARGININE METHYL ESTER; PARACETAMOL; PETHIDINE; PLACEBO; PROPACETAMOL; TENOXICAM; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VERAPAMIL;

ACUTE TOXICITY; ANALGESIA; ANALGESIC ACTIVITY; ANGINA PECTORIS; ANXIETY; BACKACHE; BILIARY COLIC; CANCER PAIN; CHRONOBIOLOGY; CHRONOPHARMACOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; COMPUTER; COMPUTER CONTROLLED ANALGESIA; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG POTENTIATION; DRUG PROTEIN BINDING; DRUG WITHDRAWAL; ELECTRIC SHOCK; ELECTROSTIMULATION; FIBROMYALGIA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART INFARCTION; HUMAN; HYPERTENSION; IMPLANT; INTRACTABLE PAIN; KIDNEY COLIC; LABOR PAIN; LD 50; MIGRAINE; MOUSE; NAUSEA; NEUROCHEMISTRY; NONHUMAN; OSTEOARTHRITIS; PAIN; PATIENT CONTROLLED ANALGESIA; PLASMA CLEARANCE; PRIORITY JOURNAL; RAT; REVIEW; RHEUMATOID ARTHRITIS; SICKLE CELL ANEMIA; SIDE EFFECT; SINGLE DRUG DOSE; STOMACH PAIN; SUSTAINED RELEASE FORMULATION; TOOTH PAIN; TRANSDERMAL PATCH; VERTIGO; VOLUNTEER;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONOBIOLOGY; CIRCADIAN RHYTHM; DRUG DELIVERY SYSTEMS; HUMANS; PAIN; THERAPY, COMPUTER-ASSISTED;

EID: 34948884624     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2006.06.001     Document Type: Review

References (120)

1. Frederickson R.C., Burgis V., and Edwards J.D. Hyperalgesia induced by naloxone follows diurnal rhythm in responsivity to painful stimuli. Science 198 (1977) 756-758
2. Wesche D.L., and Frederickson R.C.A. Diurnal differences in opioid peptide levels correlated with nociceptive sensitivity. Life Sci. 24 (1979) 1861-1868
3. Lutsch E.F., and Morris R.W. Circadian periodicity in susceptibility to lidocaine hydrochloride. Sciences 15 (1967) 100-102
4. Kavaliers M., and Hirst M. Daily rhythms of analgesia in mice: effects of age and photoperiod. Brain Res. 279 (1983) 387-393
5. Gschossmann J.M., Buenger L., Adam B., Liebregts T., Saller B., Mann K., Gerken G., and Holtmann G. Diurnal variation of abdominal motor responses to colorectal distension and plasma cortisol levels in rats. Neurogastroenterol. Motil. 13 (2001) 585-589
6. Martin E.G., Bigelow G.H., and Grabfield G.B. Variations in the sensory threshold for faradic stimulation in normal human subjects.II. The nocturnal rhythm. Am. J. Physiol. 33 (1914) 415-422
7. Grabfield G.P., and Martin E.G. Variation in the sensory threshold for faradic stimulation in normal human subject. Am. J. Physiol. 31 (1912) 300-308
8. Macht D.J., Herman N.B., and Levy C.S. A quantitative study of the analgesia produced by opium alkaloids, individually and in combination with each other in normal man. J. Pharmacol. Exp. Ther. 8 (1916) 1-37
9. Hardy D.J., Wolff H.G., and Goodell H. Studies on pain. A new method for measuring pain: observations on spatial summation of pain. J. Clin. Invest. 19 (1940) 649-657
10. Schumacher G.A., Goodell H., Hardy J.F., and Wolff H.G. Uniformity of pain threshold in man. Science 92 (1940) 110-112
11. Chapman P., and Jones C.M. Variations in cutaneous and visceral pain sensitivity in normal subjects. J. Clin. Invest. 23 (1944) 81-91
12. Procacci P., Moretti R., Zoppi M., Capelletti C., and Vogelin M.R. Rythmes circadien et circatrigindien du seuil de la douleur cutanée chez l'homme. Bull. Groupe Rythm. Biol. 5 (1973) 65-75
13. Procacci P., Corte M.D., Zoppi M., and Maresca M. Rhythmic changes of the cutaneous pain threshold in man. A general review. Chronobiologia 1 (1974) 77-96
14. Davis G.C., Buchsbaum M.S., and Bunnew W.E. Naloxone decreases diurnal variations in pain sensitivity and somatosensory evoked potentials. Life Sci. 23 (1978) 1449-1460
15. Stacher G., Bauer P., Schneider C., Winklehner S., and Schmierer G. Effects of combination of oral naproxen sodium and codeine in experimentally induced pain. Eur. J. Clin. Pharmacol. 1 (1982) 485-490
16. Pöllmann L. Duality of pain demonstrated by the circadian variation in tooth sensibility. In: Haus E., and Kabat H. (Eds). Chronobiology 1982-1983 (1984), Karger, Basle 225-228
17. Morawetz R.F., Parth P., and Poppel E. Influence of the pain measurement technique on the diurnal variation of pain perception. In: Bromm B. (Ed). Pain measurement in man (1984), Elsevier, Amsterdam 409-415
18. Strian F., Lautenbacher S., Galfe G., and Holzl R. Diurnal variations in pain perception and thermal sensitivity. Pain 36 (1989) 125-131
19. Gobel H., and Cordes P. Circadian variation of pain sensitivity in pericranial musculature. Headache 30 (1990) 418-422
20. Bourdalle-Badie C., Andre M., Pourquier P., Robert S., Cambar J., and Erny P. Circadian rhythm of pain in man: study by measure of nociceptive flexion reflex. Annu. Rev. Chronopharmacol. 7 (1990) 249-252
21. Hummel T., Kraetsch H.G., Lotsch J., Hepper M., Liefhold J., and Kobal G. Analgesic effects of dihydrocodeine and tramadol when administered either in the morning or evening. Chronobiol. Int. 12 (1995) 62-72
22. Kobal G., Hummel T., Kraetsch H.G., and Lötsch J. Circadian analgesic effect of dihydromorphione and tramadol. 5th Int Conf. Biological Rhythms and Medications, Amelia Island (Fl) (1992) abstract XIII-5
23. Koch H.J., and Raschka C. Diurnal variation of pain perception in young volunteers using the tourniquet pain model. Chronobiol. Int. 21 (2004) 171-173
24. Pöllmann L. Circadian variation of potency of placebo as analgesic. Funct. Neurology 22 (1987) 99-103
25. Cannon C.P., McCabe C.H., Stone P.H., Schactman M., Thompson B., Theroux P., Gibson R.S., Feldman T., Kleiman N.S., Tofler G.H., Muller J.E., Chaitman B.R., and Braunwald E. Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB). Am. J. Cardiol. 79 (1997) 253-258
26. Master A.M. The role of effort and occupation (including physicians) in coronary occlusion. J. Am. Med. Assoc. 174 (1960) 942-948
27. Muller J.E., Stone P.H., and Turin Z.G. The Millis Study Group: circadian variation in the frequency of onset of acute myocardial infarction. N. Engl. J. Med. 313 (1985) 1315-1322
28. Pownall R., and Pickvance N.J. Does treatment matter? A double blind crossover study of ibuprofen 2400 mg per day in different dosage schedules in treatment of chronic low back pain. Br. J. Clin. Pract. 39 (1985) 267-275
29. Pednault L., and Parent M. Circadian rhythm of chronic low back pain caused by discal degeneration, fusion pseudarthrose or discoidectomy. In: Labrecque G. (Ed). Proceedings of the 21st Conference of the International Society for Chronobiology, Quebec, Canada (1993) III-9 Québec
30. Rigas B., Torosis J., McDougall C.J., Vener K.J., and Spiro H.M. The circadian rhythm of biliary colic. J. Clin. Gastroenterol. 12 (1990) 409-414
31. Sittl R., Kamp H.D., and Knoll R. Zirkadiane rhythmic des Schmerzempfindens bei tumorpatienten. Nevenheilkunde 9 (1990) 22-24
32. Bellamy N., Sothern R.B., and Campbell J. Aspects of diurnal rhythmicity in pain, stiffness, and fatigue in patients with fibromyalgia. J. Rheumatol. 31 (2004) 379-389
33. Orr W.C. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management. Eur. J. Gastroenterol. Hepatol. 17 (2005) 113-120
34. Folkard S., Glynn C.J., and Lloyd J.W. Diurnal variation and individual differences in the perception of intractable pain. J. Psychosom. Res. 20 (1976) 289-301
35. Aya A.G., Vialles N., Mangin R., Robert C., Ferrer J.M., Ripart J., and de La Coussaye J.E. Chronobiology of labour pain perception: an observational study. Br. J. Anaesth. 93 (2004) 451-453
36. Solomon G.D. Circadian rhythms and migraine. Clevel. Clin. J. Med. 59 (1992) 326-329
37. Waters W.E., and O'Connors P.J. Epidemiology of headache and migraine in women. J. Neurol. Neurosurg. Psychiatry 34 (1971) 148-153
38. Job-Deslandre C., Reinberg A., and Delbarre F. Chronoeffectiveness of indomethacin in four patients suffering from an evolutive osteoarthritis of hip or knee. Chronobiologia 10 (1983) 245-254
39. Lévi F., Le Louarn C., and Reinberg A. Timing optimizes sustained-release indomethacin treatment of osteoarthritis. Clin. Pharmacol. Ther. 37 (1985) 77-84
40. Bellamy N., Sothern R.B., and Campbell J. Rhythmic variations in pain perception in osteoarthritis of the knee. J. Rheumatol. 17 (1990) 364-372
41. Bellamy N., Sothern R.B., Campbell J., and Buchanan W.W. Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann. Rheum. Dis. 61 (2002) 1075
42. Manfredini R., Gallerani M., Cecilia O., Boari B., Fersini C., and Portaluppi F. Circadian pattern in occurrence of renal colic in an emergency department: analysis of patients' notes. Br. Med. J. 324 (2002) 767
43. Boari B., and Manfredini R. Circadian rhythm and renal colic. Recent Prog. Med. 94 (2003) 191-193
44. Kowanko I.C., Pownall R., Knapp M.S., Swannel E.J., and Mahoney P.G. Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of the day. Br. J. Clin. Pharmacol. 11 (1981) 477-484
45. Cutolo M., and Masi A.T. Circadian rhythms and arthritis. Rheum. Dis. Clin. North Am. 31 (2005) 115-129
46. Pöllman L. Circadian changes in the duration of local anaesthesia. J. Interdiscip. Cycle Res. 12 (1981) 187-191
47. Auvil-Novak S.E. The chronobiology, chronopharmacology, and chronotherapeutics of pain. Annu. Rev. Nurs. Res. 17 (1999) 133-153
48. Kelderlhue B., Palkovits M., Karteszi M., and Reinberg A. Circadian parathion in substance P, luliverin (LH-RH) and thyroliberin (TRH) contents in hypothalamic and extra hypothalamic brain nuclei of adult rats. Brain Res. 206 (1981) 405-413
49. Labrecque G., and Vanier M.C. Rhythms, pain and pain management. In: Redfern P. (Ed). Chronotherapeutics (2003), Pharmaceutical Press, London 212-233
50. Pikula D.L., Harris E.F., Desiderio D.M., Fridland G.H., and Lovelace J.L. Methionine enkephalin-like, substance P-like, and beta-endorphin-like immunoreactivity in human parotid saliva. Arch. Oral Biol. 37 (1992) 705-709
51. Barni S., Lissoni P., Rovelli F., Crispino S., Paolorossi F., Esposti D., Fraschini F., and Tancini G. Alteration of opioid peptide circadian rhythm in cancer patients. Tumori 74 (1988) 357-360
52. Leone M., Lucini V., D'Amico D., Moschiano F., Maltempo C., Fraschini F., and Bussone G. Twenty four hour melatonin and cortisol plasma levels in relation to timing of cluster headache. Cephalalgia 15 (1995) 224-239
53. Shavali S., Ho B., Govitrapong P., Sawlom S., Ajjimaporn A., Klongpanichapak S., and Ebadi M. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res. Bull. 64 (2005) 471-479
54. J.J. Virey; Ephémérides de la vie humaine ou recherches sur la révolution journalière, et la périodicité de ses phénomènes dans la santé et les maladies. Thèse de médecine, Université de Paris. 1814.
55. Bélanger P.M., Lalande M., Doré F., and Labrecque G. Diurnal variations in the transferase and hydrolases involved in glucuronide and sulfate conjugation of rat liver. Drug Metab. Dispos. 13 (1985) 386-389
56. Kolawole J.A., Chuhwak P.D., and Okeniyi S.O. Chronopharmacokinetics of acetaminophen in healthy human volunteers. Eur. J. Drug Metab. Pharmacokinet. 27 (2002) 199-202
57. Bruguerolle B., Bouvenot G., Bartolin R., and Pouyet A. Chronokinetics of acetaminophen in elderly patients. Annu. Rev. Chronopharmacol. 7 (1990) 265-268
58. Ngong J.M., and Waring R.H. Circadian rhythms of paracetamol metabolism in healthy subjects: a preliminary report. Drug Metab. Drug Interac. 11 (1994) 317-330
59. Clench J., Reinberg A., Dziewanowska Z., Ghata J., and Smolensky M.H. Circadian changes in the bioavailability and effects of indomethacin in healthy subjects. Eur. J. Clin. Pharmacol. 20 (1981) 359-369
60. Ollagnier M., Decousus H., and Cherreah Y. Circadian changes in the pharmacokinetics of oral ketoprofen. Clin. Pharmacokinet. 12 (1987) 367-378
61. Guissou P., Cuisinaud G., Llorca G., Lejeune E., and Sassard J. Chronopharmacokinetic study of a prolonged release form of indomethacin. Eur. J. Clin. Pharmacol. 24 (1983) 667-670
62. Perpoint B., Mismetti P., Simitsidis S., Hocquart J., Rambaud C., Buchmuller A., Queneau P., and Decousus H. Dosing time optimizes sustained-release ketoprofen treatment of osteoarthritis. Chronobiol. Int. 11 (1994) 119-125
63. Lemmer B., and Bruguerolle B. Chronopharmacokinetics. Are they clinically relevant?. Clin. Pharmacokinet. 26 (1994) 419-427
64. Halsas M., Hietala J., Veski P., Jurjenson H., and Marvola M. Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations. Int. J. Pharm. 189 (1999) 179-185
65. Reinberg A., Zagula-May Z., Ghata J., and Halberg F. Circadian rhythms in duration of salicylate excretion referred to phase of excretory rhythms and route. Proc. Soc. Exp. Biol. Med. 129 (1967) 826-832
66. Ohdo S., Agawa N., and Song J.G. Chronopharmacological study of acetylsalicylic acid in mice. Eur. J. Pharmacol. 293 (1995) 151-157
67. Labrecque G., Bureau J.P., and Reinberg A.E. Biological rhythms in the inflammatory response and in the effects of non-steroidal anti-inflammatory drugs. Pharmacol. Ther. 66 (1995) 285-300
68. Cui Y., Sugimoto K., Araki N., and Fujimura A. Evaluation of chronopharmacodynamics of indomethacin by the kaolin-induced pain model in mice. Chronobiol. Int. 20 (2003) 473-484
69. Millecamps M., Jourdan D., Leger S., Etienne M., Eschalier A., and Ardid D. Circadian pattern of spontaneous behavior in monarthritic rats: a novel global approach to evaluation of chronic pain and treatment effectiveness. Arthritis Rheum. 52 (2005) 3470-3478
70. Bouchancourt P., and LeLouarn C. Étude chronothérapeutique de l'indométhacine à effet prolongé dans l'arthrose des membres inférieurs. Trib. Med. supp.1 (1982) 32-35
71. Simon L., Hérisson P., Le Louarn C., and Lévi F. Étude hospitalière de chronothérapeutique avec 75 mg d'indométhacine à effet prolongé en pathologie rhumatismale dégénerative. Trib. Med. Suppl. 1 (1982) 43-47
72. Swannel A.J. Biological rhythms and their effect in the assessment of disease activity in rheumatoid arthritis. Br. J. Clin. Pract. 38 Suppl. 33 (1983) 16-19
73. Rejholec V., Vitulova V., and Vachtenheim J. Preliminary observations from a double-blind crossover study to evaluate the efficacy of flurbiprofen given at different times of day in the treatment of rheumatoid arthritis. Annu. Rev. Chronopharmacol. 1 (1984) 357-360
74. Reinberg A., Manfredi R., Kahn M.F., Chaouat D., Chaouat Y., Delcambre B., Le Goff P., Maugars Y., and Valat J.P. Chronotherapy of tenoxicam. Therapies 46 (1991) 101-108
75. Vinje O., Fagertun H.E., Laerum E., Lund H., and Larsen S. Ketoprofen controlled release in the treatment of osteoarthrosis; a double blind, randomized multicentre study of single morning versus evening dose. Scand. J. Prim. Health Care 11 (1993) 91-97
76. Stengaard-Pedersen K., Ekesbo R., Karvonen A.L., and Lyster M. Celecoxib 200 mg i.d. is efficacious in the management of osteoarthritis of the knee or hip regardless of the time of dosing. Rheumatology 43 (2004) 592-595
77. Moore J.G., and Goo R. Day and night aspirin-induced gastric mucosal damage and protection by ranitidine in man. Chronobiol. Int. 4 (1987) 111-116
78. Nold G., Drossard K., Lehman K., and Lemmer B. Gastric mucosal lesions after morning versus evening application of 75 mg or 1000 mg acetylsalicylic Acid (ASA). Naunyn-Schmiedeberg's Arch. Pharmacol. 351 (1995) R17
79. Bruguerolle B. Time dependence of general and local anaesthetic drugs. In: Lemmer B. (Ed). Chronopharmacology, Cellular and Biochemical Interactions (1989), Marcel Dekker Inc., New York 581-596
80. Bruguerolle B. Local anaesthetics. In: Redfern P.H., and Lemmer B. (Eds). Physiology and Pharmacology of Biological Rhythms (1997), Springer-Verlag, Berlin 607-618
81. Bruguerolle B., and Prat M. Chronotoxicity and chronokinetics of two local anaesthetic agents bupivacaine and mepivacaine in mice. Ann. Rev. Chronopharmacol. 5 (1988) 227-230
82. Reinberg A., and Reinberg M.A. Circadian changes in the duration of action of local anesthetic agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 297 (1977) 149-152
83. Debon R., Chassard D., Duflo F., Boselli E., Bryssine B., and Allaouchiche B. Chronobiology of epidural ropivacaine: variations in the duration of action related to the hour of administration. Anesthesiology 96 (2002) 542-545
84. Bruguerolle B., and Isnardon R. Daily variations in plasma levels of lidocaine during local anaesthesia in dental practice. Ther. Drug Monit. 7 (1985) 369-370
85. Bruguerolle B., Dupont M., Lebre P., and Legre G. Bupivacaine chronokinetics in man after a peridural constant rate infusion. Ann. Rev. Chronopharmacol. 5 (1988) 223-226
86. Bélanger P.M., Bruguerolle B., and Labrecque G. Rhythms in Pharmacokinetics: absorption, distribution, metabolism and excretion. In: Redfern P.H., and Lemmer B. (Eds). Physiology and pharmacology of Biological Rhythms. Handbook of Experimental Pharmacology vol. 125 (1997), Springer-Verlag, Berlin 177-204
87. Bruguerolle B. Chronopharmacokinetics: current status. Clin. Pharmacokinet. 35 (1998) 83-94
88. Liu X.P., and Song J.G. Chronopharmacology of tramadol in mice. Yaoxue Xuebao 36 (2001) 561-564
89. Morris R.W., and Lutsch E.F. Susceptibility to morphine-induced analgesia in mice. Nature 216 (1967) 494-495
90. Hamra J.G., Kamerling S.G., Wolfsheimer K.J., and Bagwell C.A. Diurnal variation in plasma IR-beta-endorphin levels and experimental pain thresholds in the horse. Life Sci. 53 (1993) 121-129
91. Güney K.Z., Gorgun C.Z., Tunctan B., Uludag O., Hodoglugil U., Abacioglu N., and Zengil H. Circadian-rhythm-dependent effects of l-NG-nitroarginine methyl ester (l-NAME) on morphine-induced analgesia. Chronobiol. Int. 15 (1998) 283-289
92. Labrecque G., and Vanier M.C. Biological rhythms in pain and in the effects of opioid analgesics. Pharmacol. Ther. 68 (1995) 129-147
93. Graves D., Batenhorst R., Bennett R., Wettstein J., Griffen W., Wright B., and Foster T. Morphine requirements using patient-controlled analgesia: influence of diurnal variation and morbid obesity. Clin. Pharm. 2 (1983) 49-53
94. Auvil-Novak S.E., Novak R., Smolensky M.H., Kavanagh J.J., Kwan J.W., and Wharthon J.T. Twenty-four hour variation in self-administration of morphine sulfate and hydromorphone by postsurgical gynecologic cancer patient. Ann. Rev. Chronopharmacol. 5 (1988) 343-346
95. Auvil-Novak S.E., Novak R., Smolensky M.H., Morris M.M., and Kwan J.W. Temporal variation in the self-administration of morphine sulfate via patient-controlled analgesia in postoperative gynecologic cancer patient. Ann. Rev. Chronopharmacol. 7 (1990) 253-256
96. Labrecque G., Lepage-Savary D., and Poulin E. Time-dependent variation in morphine-induced analgesia. Ann. Rev. Chronopharmacol. 5 (1988) 135-138
97. Anastasopoulou-Sampani D., Sampanis E., and Karargiris G. The need for analgesia in elective cholecystectomies influenced by the time of day the operation is performed. Acta Anaesthesiol. Scand. 40 (1996) 955
98. Ritschel W.A., Bykadi G., Ford D.J., Bloomfield S.S., and Levy R.C. Pilot study on disposition and pain relief after i.m. administration of meperidine during the day or night. Int. J. Clin. Pharmacol. Ther. Toxicol. 21 (2003) 218-223
99. Citron M., Kaira J., Seltzer V., Hoffman M., and Walczak M. Patient-controlled analgesia for cancer pain: a long term study of inpatient and outpatient use. Cancer Investig. 10 (2002) 335-341
100. Bruera E., Macmillan K., Kuehn N., and Miller M.J. Circadian distribution of extra doses of narcotic analgesics in patients with cancer pain: a preliminary report. Pain 49 (1992) 311-314
101. Klepstad P., Skogvoll E., Kaasa S., and Borchgrevink P.C. Circadian distribution of oral opioid consumption in cancer patients. Methods Find. Exp. Clin. Pharmacol. 22 (2000) 753-755
102. Gallerani M., Manfredini R., Dal Monte D., Calo G., Brunaldi V., and Simonato M. Circadian differences in the individual sensitivity to opiate overdose. Crit. Care Med. 29 (2001) 96-101
103. Debon R., Boselli E., Guyot R., Allaouchiche B., Lemmer B., and Chassard D. Chronopharmacology of intrathecal sufentanil for labor analgesia: daily variations in duration of action. Anesthesiology 101 (2004) 978-982
104. Chassard D., and Bruguerolle B. Chronobiology and anesthesia. Anesthesiology 100 (2004) 413-427
105. Rasmussen N.A., and Farr L.A. Effects of morphine and time of day on pain and beta-endorphin. Biol. Res. Nurs. 5 (2003) 105-116
106. Gourlay G.K., Plummer J.L., and Cherry D.A. Chronopharmacokinetic variability in plasma morphine concentrations following oral doses of morphine solution. Pain 61 (1995) 375-381
107. Miaskowski C. Patient-controlled modalities for acute postoperative pain management. J. Perianesth. Nurs. 20 (2005) 255-267
108. Smith T.J., Swainey C., and Coyne P.J. Pain management, including intrathecal pumps. Curr. Pain Headache Rep. 9 (2005) 243-248
109. Fisher D.M., Kellett N., and Lenhardt R. Pharmacokinetics of an implanted osmotic pump delivering sufentanil for the treatment of chronic pain. Anesthesiology 99 (2003) 929-937
110. Smith T.J., and Coyne P.J. Implantable drug delivery systems (IDDS) after failure of comprehensive medical management (CMM) can palliate symptoms in the most refractory cancer pain patients. J. Palliat. Med. 8 (2005) 736-742
111. Lim Y., Sia A.T., and Ocampo C. Automated regular boluses for epidural analgesia: a comparison with continuous infusion. Int. J. Obstet. Anesth. 14 (2005) 305-309
112. Wermeling D.P., Grant G.M., Lee A., and Rudy N.A.C. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study. Clin. Ther. 27 (2005) 430-440
113. James M.A., Papouchado M., and Jones J.V. Attenuation of nitrate effect during an intermittent treatment regimen and thetime course of nitrate tolerance. Eur. Heart J. 12 (1991) 1266-1272
114. Bruguerolle B., Giaufre E., and Prat M. Temporal variations in transcutaneous passage of drugs: the example of lidocaine in children and in rats. Chronobiol. Int. 8 (1991) 277-282
115. Houck C.S., and Sethna N.F. Transdermal analgesia with local anesthetics in children: review, update and future directions. Expert. Rev. Neurother. 5 (2005) 625-634
116. Freynhagen R., von Giesen H.J., Busche P., Sabatowski R., Konrad C., and Grond S. Switching from reservoir to matrix systems for the transdermal delivery of fentanyl: a prospective, multicenter pilot study in outpatients with chronic pain. J. Pain Symptom. Manage. 30 (2005) 289-297
117. Mormont M.C., and Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer 97 (2003) 155-169
118. Cortinez L.I., Munoz H.R., De La Fuente R., Acuna D., and Dagnino J.A. Target-controlled infusion of remifentanyl or fentanyl during extracorporeal shock wave lithotripsy. Eur. J. Anaesthesiol. 22 (2005) 56-61
119. Bastin R., Barvais L., Melot C., Vincent J.L., and Berre J. Preliminary results of prolonged target-controlled infusion of sufentanil adjusted to an effort pain score after cardiac surgery. Acta Anaesthesiol. Belg. 56 (2005) 31-36
120. Nusstein J., Claffey E., Reader A., Beck M., and Weaver J. Anesthetic effectiveness of the supplemental intraligamentary injection, administered with a computer-controlled local anesthetic delivery system, in patients with irreversible pulpitis. J. Endod. 31 (2005) 354-358